Disease Stage-Dependent Clinical Impact of CTLA4 Polymorphism in Multiple Myeloma Treated with Autologous Stem Cell Transplantation
This germline <i>CTLA4</i> polymorphism may serve as biomarker to refine post-transplant risk stratification and enable personalized treatment management.
Authors
- Martina Bertschinger (ORCID: https://orcid.org/0000-0003-1736-812X)
- Katja Seipel (ORCID: https://orcid.org/0000-0003-3128-1573)
- Ulrike Bacher
- Pinar Horum
- Inna Shaforostova
- Thomas Pabst
Institutions
- University of Bern (CH)
- University Hospital of Bern (CH)
Publication Details
- Journal
- Cancers
- Published
- 2026-03-16
- DOI
- https://doi.org/10.3390/cancers18060963
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Inselspital, Universitätsspital Bern